Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke

Figures

• 

  Fig. 1. Flow chart of patient enrolment in our study. AF, atrial fibrillation

• 

  Fig. 2. Distribution of proportions in atrial fibrillation (AF) and non-AF subgroups among different quartiles of the systemic immune inflammation index (SIII) (A) and system inflammation response index (SIRI) (B) in patients with stroke

• 

  Fig. 3. Correlation between costs and systemic immune inflammation index (SIII) (or system inflammation response index [SIRI]). SIII and SIRI were logarithmically transformed before plotting. Hollow circles and dotted lines, non-atrial fibrillation (AF) patients (n = 353); Filled circles and solid lines, patients with AF (n = 173)

• 

  Fig. 4. Correlation between change in National Institutes of Health Stroke Scale (NIHSS) scores and systemic immune inflammation index (SIII) (or system inflammation response index [SIRI]). SIII and SIRI were logarithmically transformed before plotting. Hollow circles and dotted lines, non-atrial fibrillation (AF) patients (n = 353); Filled circles and solid lines, patients with AF (n = 173)